DiscoverNucleate PodcastPioneering Cell Therapy | Bobby Gaspar, Orchard Therapeutics
Pioneering Cell Therapy | Bobby Gaspar, Orchard Therapeutics

Pioneering Cell Therapy | Bobby Gaspar, Orchard Therapeutics

Update: 2023-12-19
Share

Description

This episode is a conversation with Prof Bobby Gaspar, the CEO of Orchard Therapeutics, a clinical stage biotech company developing gene therapies for severe diseases. Signal host Ursule Demael speaks to Prof Bobby Gaspar, who holds an MD/PhD and is an honorary professor of Paediatrics and Immunology at Great Ormond Street Hospital in London (United Kingdom). He has decades of expertise across academic research and biotech developing haematopoietic stem cell therapies for patients with immune deficiencies and metabolic disorders. Orchard’s lead therapy Libmedly is approved for the metabolic disorder MLD in Europe.

Orchard Therapeutics Website: https://www.orchard-tx.com/about/our-story/
Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Pioneering Cell Therapy | Bobby Gaspar, Orchard Therapeutics

Pioneering Cell Therapy | Bobby Gaspar, Orchard Therapeutics

Nucleate